Our results also suggest that this strategy is effective in a mouse model of obesity-induced insulin resistance, and support further efforts aimed at generating novel molecules that interfere with PED/PEA-15 and/or PLD1 functions mimicking D4 peptide action. Here, PLD1 is linked to obesity due to melanocortin 4 receptor deficiency.